ckd glp 1 Effects of Semaglutide on in Patients With Type 2 Diabetes Kidney Outcomes With Glucagon-Like Peptide-1

The skin showed erythema nodosum, pyoderma gangrenosum and nonspecific rash

Although selenium supplementation demonstrates potential benefits in reducing autoantibody levels, the existing body of researchprimarily limited to short-term observations of 36 monthsfails to establish a definitive causal relationship between decreased antibody titers and sustained functional improvements in the neurological system (264)

Although speculative, these findings imply that individuals with type 2 diabetes receiving GLP-1R and/or NPY2R agonists to treat their underlying diseases could possibly profit from both these effects

As you explore options, maintain realistic expectations and seek professional guidance

10.1038/s41574-020-0357-5 2